In vitro immunodetection of prothymosin alpha in normal and pathological conditions.
Explore this paper's citation graph
Summary
This review deals with the so far reported antibodies along with the related immunodetection methodology for ProTα (immunoassays as well as immunohistochemical, immunocytological, immunoblotting, and immunoprecipitation techniques) and its application to biological samples of interest, in health and disease states.
- Type
- review
- Published
- 2019-08-07
- Cited by
- 4
- References
- 88
- OpenAlex
- https://openalex.org/W2966825494
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:199468113
Keywords
In vitro, Pathological, Alpha (finance), Chemistry, Biology
References
- Aberrant prothymosin-alpha expression in human bladder cancer.
- Tongue sole (Cynoglossus semilaevis) prothymosin alpha: Cytokine-like activities associated with the intact protein and the C-terminal region that lead to antiviral immunity via Myd88-dependent and -independent pathways respectively.
- Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer
- Prothymosin alpha is a chromatin-remodelling protein in mammalian cells.
- Development of an ELISA for the quantification of the C-terminal decapeptide prothymosin α(100-109) in sera of mice infected with bacteria.
- Regional Distribution and Cell Type-Specific Subcellular Localization of Prothymosin Alpha in Brain
- Prognostic relevance of prothymosin-alpha expression in human upper urinary tract transitional cell carcinoma.
- Tissue concentrations of prothymosin alpha: a novel proliferation index of primary breast cancer.
- Identification of prothymosin-α1, the necrosis–apoptosis switch molecule in cortical neuronal cultures
- Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy
- Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer.
- Prothymosin-alpha and Ki-67 expression in pituitary adenomas.
- Overexpression of Prothymosin Alpha Predicts Poor Disease Outcome in Head and Neck Cancer
- Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer
- The human prothymosin alpha gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA.
- Sensing prothymosin alpha origin, mutations and conformation with monoclonal antibodies.
- Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin).
- Prothymosin α overexpression contributes to the development of pulmonary emphysema
- Prothymosin alpha in human blood.
- Apoptotic and proliferating hepatocytes differ in prothymosin α expression and cell localization
Cited by
- Development of a specific IgY-based ELISA for prothymosin alpha, a bioactive polypeptide with diagnostic and therapeutic potential
- Multidirectional Pharma-Toxicological Study on Harpagophytum procumbens DC. ex Meisn.: An IBD-Focused Investigation
- First Evidence of the Expression and Localization of Prothymosin α in Human Testis and Its Involvement in Testicular Cancers
- The simultaneous administration of microplastics and cadmium alters rat testicular activity and changes the expression of PTMA, DAAM1 and PREP
Related papers
- Study on pathological diagnosis of pathological changes of 457 patients with atypical squamous cells
- Review of clinical and pathological characteristics in 68 children with henoch-schsnlein purpura nephritics
- Pathological gambling and substance misuse: a review of the literature.
- The Clinic Means of Ultrasonic for Physical Gallbladder Bulging Pathological Changes
- Analysis of the relationship between C-reactive protein and the pathological changes of coronary atherosclerosis
- Efficacy of Fluoxatine in Treatment of Pathological Crying and Laughing after Stroke
- The clinical and pathological analysis of 1 000 cases with renal biopsies in children
- Relationship between pathological changes and grades of cervical spondylotic myelopathy
- The preoperative and postoperative changes and clinical value of serum IGF-1 in lung cancer patients